´
857
E. Wojaczynska et al. / Tetrahedron: Asymmetry 21 (2010) 853–858
2.40 (m, 1H), 3.02–3.14 (m, 2H), 3.32–3.42 (m, 2H), 3.72–3.82 (m,
1H), 4.61 (d, 1H, J = 11.7 Hz), 4.98–5.14 (m, 2H), 5.76–5.92 (m, 1H),
6.84–6.96 (m, 5H, ArH), 7.10–7.23 (m, 2H, ArH), 7.43–7.49 (m, 1H,
ArH), 7.58 (d, 1H, ArH, J = 4.6 Hz), 7.90 (d, 1H, ArH, J = 8.5 Hz), 8.91
(d, 1H, ArH, J = 4.6 Hz) ppm. 13C NMR (CDCl3): d = 27.6, 27.7, 28.0,
39.4, 41.3, 55.2, 56.1, 64.8, 114.9, 121.2, 121.4, 123.8, 126.2,
127.9, 128.2, 128.4, 130.0, 130.5, 135.4, 141.3, 141.4, 147.7,
149.4 ppm. IR (KBr): 475, 753, 1039, 1049, 1086, 1444, 1580,
2863, 2942, 3059, 3443 cmꢀ1. HRMS (ESI): 403.1847 ([M+H]+);
for (C25H27N2OS)+ M = 403.1844.
128.2, 128.6, 129.2, 129.4, 130.8, 133.1, 134.2, 137.8, 141.5,
149.9 ppm. IR (KBr): 534, 544, 593, 687, 739, 1082, 1144, 1305,
1447, 1509, 1587, 1669, 1863, 1023, 3430 cmꢀ1. HRMS (ESI):
419.1769 ([M+H]+); for (C25H27N2O2S)+ M = 419.1793.
3.2.9. (8S,9S)-9-PhSO2-epi-QN
Yield = 60%, ½a 2D0
ꢂ
¼ ꢀ22:7 (c 1.23, CH2Cl2), 1H NMR (CDCl3):
d = 0.38–0.50 (m, 1H), 1.25–1.56 (m, 4H), 2.12–2.22 (m, 1H),
2.44–2.54 (m, 1H), 2.77–2.90 (m, 2H), 3.07–3.15 (m, 1H), 3.87–
3.90 (m, 1H), 3.89 (s, 3H, OMe), 4.94–4.99 (m, 2H), 5.08 (d, 1H,
J = 11.0 Hz), 5.71–5.83 (m, 1H), 7.05 (d, 1H, J = 2.6 Hz, ArH), 7.14–
7.19 (m, 2H, ArH), 7.23–7.31 (m, 2H, ArH), 7.49 (d, 1H, J = 4.6 Hz,
ArH), 7.63–7.66 (m, 2H, ArH), 7.89 (d, 1H, J = 9.2 Hz, ArH), 8.70
(d, 1H, ArH, J = 4.6 Hz) ppm. 13C NMR (CDCl3): d = 27.2, 27.5, 27.8,
39.1, 40.4, 55.4, 55.6, 57.2, 65.7, 101.2, 114.6, 120.9, 121.1, 127.9,
128.9, 129.1, 132.2, 133.0, 136.1, 139.6, 141.4, 144.6, 147.3,
158.2 ppm. IR (KBr): 525, 592, 687, 1028, 1081, 1143, 1231,
1243, 1305, 1446, 1474, 1508, 1586, 1620, 2863, 2939, 3069,
3433 cmꢀ1. HRMS (ESI): 449.1868 ([M+H]+); for (C26H29N2O3S)+
M = 449.1899.
3.2.5. (8S,9S,SS)-9-PhSO-epi-CD
Mp = 131–133 °C, (CH2Cl2/n-hexane), ½a D20
¼ ꢀ185:0 (c 0.26,
ꢂ
CH2Cl2), 1H NMR (CDCl3): d = 0.64–0.69 (m, 1H), 1.56–1.68 (m,
4H), 2.33–2.38 (m, 1H), 2.70–2.76 (m, 1H), 2.92–2.97 (m, 1H),
3.16–3.19 (m, 1H), 3.28–3.36 (m, 1H), 3.52–3.57 (m, 1H), 4.98–
5.04 (m, 2H), 5.48 (d, 1H, J = 11.6 Hz), 5.71–5.83 (m, 1H), 6.12 (d,
1H, J = 4.7 Hz), 7.22–7.24 (m, 2H, ArH), 7.30–7.35 (m, 2H, ArH),
7.38–7.41 (m, 1H, ArH), 7.57–7.63 (m, 1H, ArH), 7.68–7.73 (m,
1H, ArH), 8.07 (d, 1H, ArH, J = 8.4 Hz), 8.24 (d, 1H, ArH,
J = 8.4 Hz), 8.57 (d, 1H, ArH, J = 4.6 Hz) ppm. 13C NMR (CDCl3):
d = 27.3, 27.6, 27.7, 38.9, 41.1, 55.8, 56.0, 66.3, 114.8, 120.5,
124.1, 126.3, 126.9, 128.3, 129.4, 130.0, 131.3, 136.8, 139.8,
140.8, 141.2, 148.4, 148.7 ppm. IR (KBr): 693, 769, 899, 1043,
1440, 1508, 1508, 1584, 1744, 2943, 3069, 3438 cmꢀ1. HRMS
(ESI): 403.1840 ([M+H]+); for (C25H27N2OS)+ M = 403.1844.
3.2.10. (8R,9R)-9-PhSO-epi-QD (diastereomeric mixture)
1H NMR (CDCl3, selected peaks): major epimer: 3.70 (OMe),
4.33, 8.63 ppm; minor epimer: 3.83 (OMe), 4.82, 8.83 ppm. The
remaining signals overlap in the 0.4–8.5 ppm region. HRMS (ESI):
433.1953 ([M+H]+); for (C26H29N2O2S)+ M = 433.1949.
3.2.6. (8S,9S,RS)-9-PhSO-epi-QN
3.2.11. (8S,9R)-9-PhSO-QN (diastereomeric mixture)
Mp = 52–53 °C ½a 2D0
ꢂ
¼ ꢀ123 (c 0.86, CH2Cl2), 1H NMR (CDCl3):
1H NMR (CDCl3, selected peaks): major epimer: 3.60 (OMe),
4.42, 8.35 ppm; minor epimer: 3.82 (OMe), 5.31, 8.80 ppm. The
remaining signals overlap in the 0.4–8.5 ppm region. HRMS (ESI):
433.1936 ([M+H]+); for (C26H29N2O2S)+ M = 433.1949.
d = 0.60–0.72 (m, 1H), 1.51–1.80 (m, 4H), 2.32–2.41 (m, 1H),
2.98–3.10 (m, 2H), 3.30–3.42 (m, 2H), 3.72 (s, 3H, OMe), 3.70–
3.81 (m, 1H), 4.49 (d, 1H, J = 11.8 Hz), 4.99–5.13 (m, 2H), 5.81–
5.93 (m, 1H), 6.39 (d, 1H, J = 2.7 Hz, ArH), 6.89–7.03 (m, 5H, ArH),
7.11–7.17 (m, 1H, ArH), 7.52 (d, 1H, J = 4.8 Hz, ArH), 7.84 (d, 1H,
J = 9.3 Hz, ArH), 8.78 (d, 1H, ArH, J = 4.2 Hz) ppm. 13C NMR (CDCl3):
d = 27.7, 27.7, 28.0, 39.4, 41.3, 55.3, 55.3, 56.1, 65.3, 100.7, 114.9,
120.1, 121.7, 124.0, 128.2, 129.0, 130.7, 131.5, 133.8, 141.3, 141.8,
143.8, 147.0, 157.4 ppm. IR (KBr): 691, 746, 853, 917, 1045, 1086,
1230, 1319, 1359, 1443, 1473, 1507, 1583, 1620, 1722, 2865,
3.3. Catalytic reaction
The Pd-catalyzed allylic substitution reaction (Trost–Tsuji reac-
tion2) of dimethyl malonate with rac-1,3-diphenyl-2-propenyl ace-
tate was performed using 3 mol % of N,O-bis(trimethylsilyl)
acetamide–potassium acetate as a base, 2.5 mol % of [Pd(g3
-
2938, 3073, 3356 cmꢀ1
.
HRMS (ESI): 433.1900 ([M+H]+); for
C3H5)Cl]2, and 10 mol % of tested chiral ligand in acetonitrile
solution. The stereochemical effect of the catalytic reaction was
determined by 1H NMR measurement using Eu(hfc)3 as a chiral
shift reagent.
(C26H29N2O2S)+ M = 433.1949. Rf (ethyl acetate) = 0.16.
3.2.7. (8S,9S,SS)-9-PhSO-epi-QN
½
a 2D0
ꢂ
¼ ꢀ215 (c 0.52, CH2Cl2), 1H NMR (CDCl3): d = 0.62–0.71 (m,
1H), 1.58–1.72 (m, 4H), 2.30–2.43 (m, 1H), 2.72–2.82 (m, 1H),
2.90–3.05 (m, 1H), 3.18–3.29 (m, 1H), 3.30–3.38 (m, 1H), 3.51–
3.62 (m, 1H), 4.00 (s, 3H, OMe), 4.98–5.10 (m, 2H), 5.33 (d, 1H,
J = 11.4 Hz), 5.72–5.85 (m, 1H), 6.13 (d, 1H, J = 4.8 Hz, ArH), 7.25–
7.49 (m, 6H, ArH), 7.47 (d, 1H, J = 2.7 Hz, ArH), 7.96 (d, 1H,
J = 9.0 Hz, ArH), 8.44 (d, 1H, ArH, J = 4.8 Hz) ppm. 13C NMR (CDCl3):
d = 27.4, 27.7, 27.8, 39.0, 41.1, 55.8, 55.9, 56.3, 67.1, 102.9, 114.7,
120.7, 121.6, 126.3, 128.3, 131.0, 131.3, 131.5, 135.5, 139.9,
141.3, 144.7, 146.2, 158.1 ppm. IR (film): 917, 1043, 1082, 1230,
1473, 1621, 1724, 2864, 2929, 3073, 3399 cmꢀ1. HRMS (ESI):
433.1921 ([M+H]+); for (C26H29N2O2S)+ M = 433.1949. Rf (ethyl
acetate) = 0.08.
Acknowledgment
We are grateful to the Polish Ministry of Science and Higher
Education for financial support; Grant No. N204 161036.
References
´
1. (a) Kacprzak, K.; Gawronski, J. Synthesis 2001, 961–998; (b) Hoffmann, H. M. R.;
Frackenpohl, J. Eur. J. Org. Chem. 2004, 4293–4312; (c) Tian, S.-K.; Chen, Y.;
Hang, J.; Tang, L.; Deng, L. Acc. Chem. Res. 2004, 37, 621–631; (d) Marcelli, T.;
van Maarseveen, J. H.; Hiemstra, H. Angew. Chem., Int. Ed. 2006, 45, 7496–7504;
(e) Connon, S. J. Chem. Commun. 2008, 2499–2510; (f) Cinchona Alkaloids in
Synthesis and Catalysis, Ligands, Immobilization and Organocatalysis; Song, C. E.,
Ed.; Wiley-VCH: Weinheim, 2009; (g) Marcelli, T.; Hiemstra, H. Synthesis 2010,
1229–1279.
3.2.8. (8S,9S)-9-PhSO2-epi-CD
2. (a) Trost, B. M.; Van Vranken, D. L. Chem. Rev. 1996, 96, 395–422; For reviews
and recent results with the heterobidentate sulfide-tertiary amine (sp3)
ligands, see: (b) Niu, J.-L.; Wang, M.-C.; Kong, P.-P.; Chen, Q.-T.; Zhu, Y.; Song,
M.-P. Tetrahedron 2009, 65, 8869–8878. and references cited therein; (c)
Mellah, M.; Voituriez, A.; Schulz, E. Chem. Rev. 2007, 107, 5133–5209; (d)
Martin, E.; Diéguez, M. C.R. Chim. 2007, 10, 188–205; (e) Masdeu-Bultó, A. M.;
Diéguez, M.; Martin, E.; Gómez, M. Coord. Chem. Rev. 2003, 242, 159–201.
Yield = 50%, ½a 2D0
ꢂ
¼ þ31:1 (c 0.74, CH2Cl2), 1H NMR (CDCl3):
d = 0.39–0.45 (m, 1H), 1.20–1.56 (m, 4H), 2.15–2.21 (m, 1H),
2.38–2.44 (m, 1H), 2.77–2.90 (m, 2H), 3.00–3.13 (m, 1H), 3.80–
3.92 (m, 1H), 4.92–5.00 (m, 2H), 5.23 (d, 1H, J = 11.4 Hz), 5.70–
5.81 (m, 1H), 7.15–7.33 (m, 3H, ArH), 7.42–7.70 (m, 5H, ArH),
7.88 (d, 1H, J = 8.1 Hz, ArH), 8.00 (d, 1H, J = 8.4 Hz, ArH), 8.84 (d,
1H, ArH, J = 4.8 Hz) ppm. 13C NMR (CDCl3): d = 27.3, 27.6, 27.8,
39.2, 40.3, 55.5, 57.4, 65.5, 114.7, 121.0, 122.1, 127.5, 128.0,
_
3. (a) Zielin´ ska-Błajet, M.; Kucharska, M.; Skarzewski, J. Synthesis 2006, 1176–
_
1182; (b) Zielin´ ska-Błajet, M.; Siedlecka, R.; Skarzewski, J. Tetrahedron:
Asymmetry 2007, 18, 131–136; (c) Zielin´ ska-Błajet, M.; Skarzewski, J.
Tetrahedron: Asymmetry 2009, 20, 1992–1998.
_